Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Workers' Comp
White Paper
Insight to the Power of 2
The Power of Data AnalyticsData, information, knowledge, action, and outcomes.
WorkCompWire
Article
WorkCompWire: Using Data to Affect Change in Workers' Comp
In "Using Data to Affect Change in
Workers' Comp
Podcast
Veterans Day Salute
WorkCompWire
Article
WorkCompWire: UR Demands Raise New Questions About URO Programs
In her article, Cathy Glade examine
PDF
Article
National Underwriter Property & Casualty: Drug of Choice
Workers' Comp
Article
StateWatch Winter 2016